# Zool719-covid19

See [Schedule here](https://docs.google.com/spreadsheets/d/1NJWmhJHhY_MuPiSu9Oii1-UA2HYzqlfMRqr88NlKtHs/edit#gid=0)

1.  January 12 Organizational meeting

2.  January 19 Literature sharing  
    2.1. (Ethan) [Lemieux, J. E., et al. 2020](https://science.sciencemag.org/content/early/2020/12/09/science.abe3261). _Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events_.  
    2.2 (Claire) [Dan, J. M., et al. 2021](https://science.sciencemag.org/content/early/2021/01/06/science.abf4063). _Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection_.  
    2.3 (Marguerite) [Powerpoint](./2.3.SARS-CoV-2%20%UK%20%SA%20%Variants%20%HiPAM%20%1_7_21.pdf). _Update on the new variants of SARS-CoV-2_  
    [Garry, R. F. 2020](https://virological.org/t/mutations-arising-in-sars-cov-2-spike-on-sustained-human-to-human-transmission-and-human-to-animal-passage/578). _Viral mutations for sustained human-human and human-animal transmission_  
    [Kemp, S. A., et al. 2020](https://doi.org/10.1101/2020.12.05.20241927). _Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation_   The first evidence of in vivo SARS-CoV-2 escape from passive antibodies and a cautionary tale for convalescent plasma use on late-stage infection. Typically convalescent plasma is used only in the earliest stages, and repeated use is not recommended.   

3.  [January 28](./Jan_28) Hawaii COVID19 model and Forecasting  
